Tim Watkins, CMO & Head of Development at Contineum Therapeutics, Inc. (CTNM), sold 7,222 shares at $14.09 ($102K) on 2026-01-28, disclosed to the SEC on 2026-01-30.
Open-market sale of $102k CTNM by CMO & Head of Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.09 | 2,800 | $39K | 38.5% |
| 2 | $14.09 | 2,800 | $39K | 38.5% |
| 3 | $14.48 | 811 | $12K | 11.5% |
| 4 | $14.48 | 811 | $12K | 11.5% |
| Total | $14.18 avg | 7,222 | $102K | 100% |
| Filing → |
| CTNM | SELL | 2025-12-30 | $44K | — | Filing → |